The urea breath test market involves procedures that use carbon or non-carbon containing stable isotopes of carbon, hydrogen or nitrogen to detect the presence of urease-producing bacteria such as Helicobacter pylori in the human stomach and duodenum. Urea breath tests have gained prominence in recent years due to their non-invasive nature and high accuracy in diagnosing Helicobacter pylori infection compared to other invasive procedures.
The Global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the urea breath test market include Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay & Grain Inc., Bailey Farms, Border Valley, Coaba, Cubeit Hay Company, Glenvar Hay, Green Prairie International, Grupo Osés, Gruppo Carli, Hay USA, Haykingdom Inc., Oregon Hay Products, Inc., Los Venteros SC, M&C Hay, Legal Alfalfa Products Ltd., Riverina (Australia) Pty Ltd, SL Follen Company, and Standlee Hay Company.
The Urea Breath Test Market Growth is expected to witness significant growth opportunities due to increasing prevalence of Helicobacter pylori infection globally and growing demand for minimally invasive diagnostic procedures. Several market players are focusing on developing advanced urea breath test kits and systems with reduced procedural time and enhanced accuracy.
Geographical expansion into emerging economies of Asia Pacific and Latin America will further aid the global proliferation of the urea breath test market over the forecast period. Increased healthcare spending and robust economic growth in developing nations has boosted the adoption of urea breath tests in these regions.
Market Drivers
The primary driver aiding the urea breath test market is increased adoption of these procedures for diagnosing Helicobacter pylori infection. Around 50% of the world’s population is infected with H. pylori, making diagnosis and treatment critical. Urea breath tests have emerged as standard protocols for non-invasive detection of H. pylori compared to invasive endoscopy or stool antigen tests. The enhanced accuracy, convenience and minimal discomfort offered by urea breath tests compared to alternatives have driven their increased usage among patients and healthcare providers globally.
PEST Analysis
Political: Urea breath tests are regulated by government bodies to ensure quality standards are maintained. Regulations influence research and approvals for new product development.
Economic: Global economic growth influences healthcare expenditure. Reimbursement policies determine affordability and access to urea breath tests. Cost-effectiveness is an important factor.
Social: Rising awareness about gut health, digestive issues and disease screening encourages adoption of urea breath tests. Social trends driving preventive healthcare increase demand.
Technological: Advancements in materials, sensors and analysis techniques aid development of easier to use, quick and affordable urea breath test kits. New technologies improve accuracy and drive the market.
The geographical regions where the urea breath test market is concentrated in terms of value include North America and Europe. These developed markets have established healthcare systems and widespread awareness about urea breath tests among patients and physicians.
The Asia Pacific region is growing the fastest for the urea breath test market. Improving economies, expanding medical capabilities and rising disease prevalence are increasing demand. Growing populations and greater health focus in countries like China and India present significant opportunities. Greater availability of diagnostics and rising disposable incomes are driving the market in the Asia Pacific.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it.